CompletedNot Applicable

Long-Term Follow-Up of HPV FOCAL Participants

Canada1,710 participantsStarted 2020-09-30

Plain-language summary

This FOCAL follow-up study aims to assess the long-term effectiveness and safety of primary HPV testing for cervical cancer screening. A cohort of participants from the original FOCAL study will be asked to see their health care provider to submit another cervical sample for cytology and HPV testing. This will permit evaluation of long term safety and effectiveness of primary HPV testing up to ten years after a participant's first screening in the FOCAL study and comparison of primary HPV testing to HPV and cytology co-testing.

Who can participate

Age range30 Years – 69 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Previous HPV FOCAL study, control arm participants who completed 48 month FOCAL LBC/HPV co-testing with no CIN2+ detected at trial exit * Resident of BC * \<69 years of age (upper age limit for routine screening per BC Cancer Cervix Screening program) * No history of CIN2+ since FOCAL study exit or in the last 5 years * Has not had a hysterectomy * Has never had a diagnosis of invasive cervical cancer

What they're measuring

Rates of CIN2+

Timeframe: 120 months

Trial details

NCT IDNCT04185389

SponsorUniversity of British Columbia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-07-14

View on ClinicalTrials.gov More Cervical Cancer trials